Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.
Chronic myeloid leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosine kinase. Imatinib mesylate (IM) is an inhibitor of BCR-ABL and has been approved for the treatment of CML. IM is well tolerated and highly efficacious as it induces stable long-t...
-д хадгалсан:
Үндсэн зохиолч: | |
---|---|
Бусад зохиолчид: | |
Формат: | Dissertation |
Хэл сонгох: | англи |
Хэвлэсэн: |
Philipps-Universität Marburg
2011
|
Нөхцлүүд: | |
Онлайн хандалт: | PDF-н бүрэн текст |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
No citations were found for this record.